In a previous paper the preparation has been described, by three different
techniques, of microparticles made of Eudragit((R)) RS 100 and RL 100 conta
ining a NSAI agent, Tolmetin. Freely flowing microparticles failed to affec
t significantly the in vitro drug release, which displayed a similar dissol
ution profile after micro-encapsulation to the free drug powder. Microparti
cles were then converted into tablets and the effect of compression on drug
deliver, as well as that of the presence of co-additives, was studied in t
he present work. Furthermore, microparticles were also prepared by adding M
gO to the polymer matrix, to reduce the sensitivity of the drug to pH chang
es during its dissolution. Similarly, magnesium stearate was also used for
microparticle formation as a droplet stabilizer, in order to reduce particl
e size and hinder rapid drug release. A mathematical evaluation, by using t
wo semi-empirical equations, was applied to evaluate the influence of disso
lution and diffusion phenomena upon drug release from microparticle tablets
.